Epicardial vasospasm and concomitant ventricular tachycardia treated with Beta-1-specific Beta-blockade: a case series in support of nebivolol
Selective beta-blockade may represent a therapeutic option in patients with high-risk epicardial spasm and ventricular arrhythmias. Furthermore, the apparent success of nebivolol in this setting suggests that hyperactive sympathetic input may represent a causal or aggravating factor in spasm-associated ventricular arrhythmias.
Authors
- Michaël McCarthy (ORCID: https://orcid.org/0000-0002-4615-8837)
- Steven E.S. Miner (ORCID: https://orcid.org/0000-0002-0783-3545)
- Laurie‐Anne Boivin‐Proulx (ORCID: https://orcid.org/0000-0003-3017-7512)
- Lynne E. Nield (ORCID: https://orcid.org/0000-0003-1301-0227)
- Steven Merritt Miner (ORCID: https://orcid.org/0009-0008-3881-3484)
- M. M. Sadek
Institutions
- Sunnybrook Health Science Centre (CA)
- University of Ottawa (CA)
- University of Toronto (CA)
- York University (CA)
- Canada Research Chairs (CA)
- Southlake Regional Health Center (CA)
- Health Sciences Centre (CA)
- McGill University (CA)
Publication Details
- Journal
- European Heart Journal - Case Reports
- Published
- 2025-12-13
- DOI
- https://doi.org/10.1093/ehjcr/ytaf641
- Primary Topic
- Cardiac Imaging and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00